Nanobodies in cytokine ‑mediated immunotherapy and immunoimaging (Review)

Int J Mol Med. 2024 Feb;53(2):12. doi: 10.3892/ijmm.2023.5336. Epub 2023 Dec 8.ABSTRACTCytokines are the main regulators of innate and adaptive immunity, mediating communications between the cells of the immune system and regulating biological functions, including cell motility, differentiation, growth and apoptosis. Cytokines and cytokine receptors have been used in the treatment of tumors and autoimmune diseases, and to intervene in cytokine storms. Indeed, the use of monoclonal antibodies to block cytokine‑receptor interactions, as well as antibody‑cytokine fusion proteins has exhibited immense potential for the treatment of tumors and autoimmune diseases. Compared with these traditional types of antibodies, nanobodies not only maintain a high affinity and specificity, but also have the advantages of high thermal stability, a high capacity for chemical manipulation, low immunogenicity, good tissue permeability, rapid clearance and economic production. Thus, nanobodies have extensive potential for use in the diagnosis and treatment of cytokine‑related diseases. The present review summarizes the application of nanobodies in cytokine‑mediated immunotherapy and immunoimaging.PMID:38063273 | DOI:10.3892/ijmm.2023.5336
Source: International Journal of Molecular Medicine - Category: Molecular Biology Authors: Source Type: research